세계의 방출 제어형 약물전달 시장 : 기술별, 치료 분야별, 용도별, 지역별
Controlled Release Drug Delivery Market, By Technology, By Therapeutic Area, By Application, By Geography
상품코드
:
1529583
리서치사
:
Coherent Market Insights
발행일
:
2024년 07월
페이지 정보
:
영문
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
세계의 방출 제어형 약물전달 시장은 2024년에는 525억 달러로 추정되며, 2024-2031년의 CAGR은 10.6%를 나타내며 2031년에는 1,061억 달러에 이를 것으로 예측됩니다.
| 보고 범위 |
보고서 세부정보 |
| 기준년 |
2023년 |
2024년 시장 규모 |
525억 달러 |
| 실적 데이터 |
2019-2023년 |
예측 기간 |
2024-2031년 |
| 예측기간 2024-2031년 CAGR |
10.60% |
2031년 금액 예측 |
1,061억 달러 |
그림. 방출 제어형 약물전달 시장 점유율(%)(2024년, 지역별)
방출 제어형 약물전달은 의약 활성 화합물 및 약물을 수시간 내지 수일의 장기간에 걸쳐 전달하는데 도움이 됩니다. 기존의 약물 전달과 비교하여 투여 횟수 감소, 치료 효과 향상, 부작용 감소 등 몇 가지 장점이 있습니다. 만성 질환의 유병률 증가, 노인 인구 증가, 대기업의 R&D 투자 증가, 기술 진보 등의 요인이 시장 성장을 뒷받침하고 있습니다. 그러나, 방출 제어형 제제의 개발과 관련된 높은 비용과 엄격한 규제 당국의 승인 프로세스가 시장 진출기업에게 과제가 될 수 있습니다.
시장 역학:
세계의 방출 제어형 약물 전달 시장의 성장은 당뇨병, 암, 심혈관 질환 등 만성 질환의 유병률 상승이 견인하고 있습니다. WHO에 따르면 2020년에는 만성질환이 세계 사인의 70% 이상을 차지한다고 합니다. 방출 제어형 약물은 장기간에 걸쳐 체내 약물 농도를 일정하게 유지함으로써 만성 질환의 관리를 개선하는 데 도움이 됩니다. 만성 질환에 걸리기 쉬운 노인 인구 증가도 시장 성장의 원동력이 됩니다. 그러나, 방출 제어형 제제의 개발에 따른 비용의 높이나 임상시험 기간의 길이가 시장 성장의 방해가 될 가능성이 있습니다. 방출 제어형 약물 전달 메커니즘의 기술적 진보, 장기간 작용하는 의약품에 대한 선호도 증가, 희귀질환을 위한 특수 의약품 개발에 주력하는 것은 시장 진출기업에게 성장 기회를 제공할 수 있습니다.
본 조사의 주요 특징
- 본 보고서에서는 세계의 방출 제어형 약물전달 시장을 상세하게 분석하여 2023년을 기준년으로 한 예측기간(2024-2031년) 시장 규모(10억 달러)와 연간 평균 성장률(CAGR%) 를 게시합니다.
- 또한 다양한 부문에 걸친 잠재적인 수익 기회를 밝히고 이 시장의 매력적인 투자 제안 행렬을 설명합니다.
- 또한 시장 성장 촉진요인, 억제요인, 기회, 신제품의 상시 및 승인, 시장 동향, 지역별 전망, 주요 기업이 채용하는 경쟁 전략 등에 관한 중요한 고찰도 제공합니다.
- 엔터프라이즈 하이라이트, 제품 포트폴리오, 주요 하이라이트, 재무 실적, 전략 등과 같은 매개변수를 기반으로 세계의 방출 제어형 약물전달 시장의 주요 기업을 프로파일링합니다.
- 이 보고서를 통해 통찰력은 마케팅 담당자와 기업 경영진이 향후 제품 출시, 유형 업그레이드, 시장 확대, 마케팅 전술에 대한 정보를 바탕으로 의사 결정을 내릴 수 있도록 합니다.
- 세계의 방출 제어형 약물전달 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 참가자, 재무 분석가 등 이 업계의 다양한 이해관계자를 지원합니다.
- 이해관계자는 세계의 방출 제어형 약물전달 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 용이하게 할 수 있습니다.
목차
제1장 조사의 목적과 전제조건
제2장 시장 전망
- 보고서 설명
- 주요 요약
- Coherent Opportunity Map (COM)
제3장 시장 역학, 규제, 동향 분석
- 시장 역학
- 영향 분석
- 시장 동향
- 규제 시나리오
- 인수와 제휴 시나리오
- 자금 조달 및 투자
- PEST 분석
- Porter's Five Forces 분석
제4장 세계의 방출 제어형 약물전달 시장-코로나 바이러스(COVID-19) 팬데믹의 영향
- 전체적인 영향
- 정부의 대처
- COVID-19에 의한 시장에 대한 영향
제5장 세계의 방출 제어형 약물전달 시장, 기술별, 2019-2031년(10억 달러)
- 소개
- Wurster 기술
- 코아세르베이션
- 마이크로 캡슐화
- 경피
- 표적 전달
- 기타
제6장 세계의 방출 제어형 약물전달 시장, 치료 분야별, 2019-2031년(10억 달러)
- 소개
- 감염증
- 종양학
- 심장병학
- 신경학
- 자가면역질환
- 기타
제7장 세계의 방출 제어형 약물전달 시장, 용도별, 2019-2031년(10억 달러)
- 소개
- 정량 흡입기
- 주사제
- 주입 펌프
- 약제 용출 스텐트
- 기타
제8장 세계의 방출 제어형 약물전달 시장, 유통 채널별, 2019-2031년(10억 달러)
제9장 세계의 방출 제어형 약물전달 시장, 지역별, 2019-2031년(10억 달러)
제10장 경쟁 구도
- 기업 프로파일
- Orbis Biosciences, Inc.
- Merck and Co., Inc.
- Alkermes plc
- Johnson and Johnson
- Coating Place, Inc.
- Corium International, Inc.
- Depomed, Inc.
- Pfizer, Inc
- Aradigm Corporation
- Capsugel.
- Abbott Laboratories
- Roche Holdings AG
- AstraZeneca
- Baxter International Inc
- Teva Pharmaceutical Industries Ltd.
- Bristol-Myers Squibb Company
제11장 분석가 추천
제12장 참고문헌과 조사방법
JHS
영문 목차
Global controlled release drug delivery market is estimated to be valued at USD 52.5 Bn in 2024 and is expected to reach USD 106.1 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 10.6% from 2024 to 2031.
| Report Coverage |
Report Details |
| Base Year: |
2023 |
Market Size in 2024: |
US$ 52.5 Bn |
| Historical Data for: |
2019 to 2023 |
Forecast Period: |
2024 to 2031 |
| Forecast Period 2024 to 2031 CAGR: |
10.60% |
2031 Value Projection: |
US$ 106.1 Bn |
Figure.Controlled Release Drug Delivery Market Share (%), By Region 2024
Controlled release delivery mechanism helps in delivering a pharmaceutical active compound or drug over an extended period of time, from hours to days. It offers several advantages over conventional drug delivery such as reduced dosing frequency, better therapeutic effectiveness and lower side effects. Factors such as growing prevalence of chronic diseases, rising geriatric population, increasing R&D investments by major players and technological advancements can drive the market growth. However, high costs associated with developing controlled release products and stringent regulatory approval process can pose challenges for the market players.
Market Dynamics:
Global controlled release drug delivery market growth is driven by rising prevalence of chronic diseases such as diabetes, cancer and cardiovascular diseases. According to the WHO, chronic diseases accounted for over 70% deaths worldwide in 2020. Controlled release drugs help in better management of chronic conditions through constant drug levels in the body over an extended time period. Growing geriatric population prone to chronic illnesses can also drive the market growth. However, high costs associated with developing controlled release formulations and long duration of clinical trials can hamper the market growth. Technological advancements in controlled release drug delivery mechanisms, growing preference for long-acting pharmaceuticals, and focus on developing specialty drugs for orphan diseases can offer growth opportunities for market players.
Key features of the study:
- This report provides in-depth analysis of the global controlled release drug delivery market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year.
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global controlled release drug delivery market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
- Key companies covered as a part of this study include Depomed, Coating Place, Corium, and Johnson and Johnson
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
- Global controlled release drug delivery market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global controlled release drug delivery market.
Detailed Segmentation-
- By Technology
- Wurster Technique
- Coacervation
- Micro Encapsulation
- Transdermal
- Targeted Delivery
- Others
- By Therapeutic Area
- Infectious Diseases
- Oncology
- Cardiology
- Neurology
- Autoimmune Diseases
- Others
- By Application
- Metered Dose Inhalers
- Injectables
- Infusion Pumps
- Drug Eluting Stents
- Others
- By Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
- Company Profiles:
- Orbis Biosciences, Inc.
- Merck and Co., Inc.
- Alkermes plc
- Johnson and Johnson
- Coating Place, Inc.
- Corium International, Inc.
- Depomed, Inc.
- Pfizer, Inc
- Aradigm Corporation
- Abbott Laboratories
- Roche Holdings AG
- AstraZeneca
- Baxter International Inc
- Teva Pharmaceutical Industries Ltd.
- Bristol-Myers Squibb Company
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Technology
- Market Snapshot, By Therapeutic Area
- Market Snapshot, By Application
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Opportunities
- Impact Analysis
- Market Trends
- Key Developments
- Regulatory Scenario
- Acquisitions and Partnerships Scenario
- Funding and Investments
- PEST Analysis
- Porter's Analysis
4. Global Controlled Release Drug Delivery Market - Impact of Coronavirus (COVID-19) Pandemic
- Overall Impact
- Government Initiatives
- COVID-19 Impact on the Market
5. Global Controlled Release Drug Delivery Market, By Technology, 2019 - 2031, (USD Bn)
- Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
- Wurster Technique
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Coacervation
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Micro Encapsulation
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Transdermal
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Targeted Delivery
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
6. Global Controlled Release Drug Delivery Market, By Therapeutic Area, 2019 - 2031, (USD Bn)
- Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
- Infectious Diseases
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Oncology
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Cardiology
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Neurology
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Autoimmune Diseases
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
7. Global Controlled Release Drug Delivery Market, By Application, 2019 - 2031, (USD Bn)
- Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
- Metered Dose Inhalers
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Injectables
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Infusion Pumps
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Drug Eluting Stents
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
8. Global Controlled Release Drug Delivery Market, By Distribution Channel, 2019 - 2031, (USD Bn)
- Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
- Hospital Pharmacy
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Retail Pharmacy
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Online Pharmacy
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
9. Global Controlled Release Drug Delivery Market, By Region, 2019 - 2031, (USD Bn)
- Introduction
- Market Share Analysis, By Region, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, For Region, 2019-2031
- Regional Trends
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- GCC
- Israel
- Rest of Middle East
- Africa
- North Africa
- Central Africa
- South Africa
10. Competitive Landscape
- Company Profiles
- Orbis Biosciences, Inc.
- Company Highlights
- Therapeutic Area Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Merck and Co., Inc.
- Alkermes plc
- Johnson and Johnson
- Coating Place, Inc.
- Corium International, Inc.
- Depomed, Inc.
- Pfizer, Inc
- Aradigm Corporation
- Capsugel.
- Abbott Laboratories
- Roche Holdings AG
- AstraZeneca
- Baxter International Inc
- Teva Pharmaceutical Industries Ltd.
- Bristol-Myers Squibb Company
11. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
12. References and Research Methodology
- References
- Research Methodology
- About us and Sales Contact
관련자료
